“Despite a challenging footwear market that resulted in our earnings to be less than expected, Caleres made excellent progress on a range of value-creating strategic objectives during 2019”, commented Diane Sullivan, CEO, President and Chairman of Caleres.

Consolidated sales of 698.9 million US dollars were down by approximately 3.0%, with Famous Footwear total sales of 369.5 million US dollars, up by 1.2%, with same-store-sales up by 5.1% and Brand Portfolio sales of 346.0 million US dollars, down by 9.4%. Adjusted net earnings in the period totalled 13.94 million US dollars.

Consolidated sales of 2 921.6 million US dollars were up 3.1%, with Brand Portfolio sales of 1 406.5 million US dollars, up by 7.1%, driven by the company’s 2018 acquisitions and Famous Footwear total sales of 1 588.1 million US dollars, down by 1.2%, with same-store-sales up by 2.0%. Caleres registered adjusted net earnings of 86.4 million US dollars, down by approximately 9%.

“Looking ahead, in the short-term, we do anticipate disruptions related to the Coronavirus and are expecting headwinds between 0.15 US dollars and 0.20 US dollars per share in the first quarter of 2020. While potential impacts on full year 2020 results are difficult to quantify at this early stage, we will continue to actively assess the situation. We are approaching 2020 with a laser focus on managing the variables within our control and leveraging the capabilities of our operations and the investments we’ve made for the future. We are confident in the strength of our portfolio and firmly believe we have the right team and right strategy in place to manage through this dynamic marketplace”, Sullivan concluded.

With a legacy of 140 years, Caleres is present in 70 countries, through its 1 200 branded retail locations, department and specialty stores, branded e-commerce sites and third-party retail sites. The portfolio of brands includes Famous Footwear, Sam Edelman, Naturalizer, Allen Edmonds, Vionic, and Dr. Scholl’s Shoes. Caleres counts with 11 500 employees.